Moleculin Biotech reports Q2 2026 financial results
Moleculin Biotech (MBRX) reports its second quarter 2026 financial results and highlights continued advancement of its pivotal MIRACLE trial.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.